The “Genetic Biomarkers” view of the KC integrates all alteration types affecting a gene of interest, e.g., BRAF in a 59-year-old male with parotid gland carcinoma harboring a previously unknown AGK::BRAF fusion that resulted from a genomic inversion reported as a structural variant (SV; Fig. 3a). This evidence concerns the gene BRAF and carcinoma of parotid gland.